Ian Mortimer is the President and CEO of Xenon Pharmaceuticals Inc., a biopharmaceutical company focused on developing novel therapies for neurological.
Ian Mortimer is the President and CEO of Xenon Pharmaceuticals Inc., a biopharmaceutical company focused on developing novel therapies for neurological and neuromuscular disorders. He oversees the company's strategic expansion and financial stability, maintaining over $500 million in cash as of late 2024 to guide operations into 2027.
Full founder directory · Investor directory · Company funding database · Fundraising library